Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

FF vs REX vs GPRE vs BIOX

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
FF
FutureFuel Corp.

Chemicals

Basic MaterialsNYSE • US
Market Cap$211M
5Y Perf.-63.3%
REX
REX American Resources Corporation

Chemicals - Specialty

Basic MaterialsNYSE • US
Market Cap$1.60B
5Y Perf.+398.3%
GPRE
Green Plains Inc.

Chemicals - Specialty

Basic MaterialsNASDAQ • US
Market Cap$1.15B
5Y Perf.+92.5%
BIOX
Bioceres Crop Solutions Corp.

Agricultural Inputs

Basic MaterialsNASDAQ • AR
Market Cap$30M
5Y Perf.-92.9%

FF vs REX vs GPRE vs BIOX — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
FF logoFF
REX logoREX
GPRE logoGPRE
BIOX logoBIOX
IndustryChemicalsChemicals - SpecialtyChemicals - SpecialtyAgricultural Inputs
Market Cap$211M$1.60B$1.15B$30M
Revenue (TTM)$96M$651M$1.94B$318M
Net Income (TTM)$-49M$50M$-15M$-53M
Gross Margin0.1%12.7%1.8%39.1%
Operating Margin-55.3%8.6%1.2%0.2%
Forward P/E62.8x46.6x
Total Debt$0.00$21M$508M$277M
Cash & Equiv.$51M$196M$182M$33M

FF vs REX vs GPRE vs BIOXLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

FF
REX
GPRE
BIOX
StockMay 20May 26Return
FutureFuel Corp. (FF)10036.7-63.3%
REX American Resour… (REX)100498.3+398.3%
Green Plains Inc. (GPRE)100192.5+92.5%
Bioceres Crop Solut… (BIOX)1007.1-92.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: FF vs REX vs GPRE vs BIOX

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: REX and GPRE are tied at the top with 3 categories each — the right choice depends on your priorities. Green Plains Inc. is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. FF also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
FF
FutureFuel Corp.
The Income Pick

FF is the clearest fit if your priority is income & stability.

  • Dividend streak 0 yrs, beta 0.49, yield 0.0%
  • 0.0% yield; the other 3 pay no meaningful dividend
Best for: income & stability
REX
REX American Resources Corporation
The Growth Play

REX carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth -22.9%, EPS growth -4.9%, 3Y rev CAGR -6.1%
  • 464.7% 10Y total return vs FF's 55.5%
  • Lower volatility, beta 0.36, Low D/E 3.3%, current ratio 8.64x
  • Beta 0.36, current ratio 8.64x
Best for: growth exposure and long-term compounding
GPRE
Green Plains Inc.
The Growth Leader

GPRE is the #2 pick in this set and the best alternative if growth and value is your priority.

  • -14.9% revenue growth vs FF's -60.7%
  • Lower P/E (46.6x vs 62.8x)
  • +336.6% vs BIOX's -88.5%
Best for: growth and value
BIOX
Bioceres Crop Solutions Corp.
The Secondary Option

BIOX lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: basic materials exposure
See the full category breakdown
CategoryWinnerWhy
GrowthGPRE logoGPRE-14.9% revenue growth vs FF's -60.7%
ValueGPRE logoGPRELower P/E (46.6x vs 62.8x)
Quality / MarginsREX logoREX7.7% margin vs FF's -51.6%
Stability / SafetyREX logoREXBeta 0.36 vs BIOX's 1.94, lower leverage
DividendsFF logoFF0.0% yield; the other 3 pay no meaningful dividend
Momentum (1Y)GPRE logoGPRE+336.6% vs BIOX's -88.5%
Efficiency (ROA)REX logoREX6.7% ROA vs FF's -23.5%, ROIC 11.4% vs -39.8%

FF vs REX vs GPRE vs BIOX — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

FFFutureFuel Corp.
FY 2025
Chemicals
62.2%$60M
Biofuels
37.8%$36M
REXREX American Resources Corporation
FY 2024
Other Member
100.0%$329,000
GPREGreen Plains Inc.
FY 2025
Products And Services Other
101.2%$94M
Intersegment Revenues
-1.2%$-1,119,000
BIOXBioceres Crop Solutions Corp.

Segment breakdown not available.

FF vs REX vs GPRE vs BIOX — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLREXLAGGINGGPRE

Income & Cash Flow (Last 12 Months)

REX leads this category, winning 3 of 6 comparable metrics.

GPRE is the larger business by revenue, generating $1.9B annually — 20.2x FF's $96M. REX is the more profitable business, keeping 7.7% of every revenue dollar as net income compared to FF's -51.6%. On growth, REX holds the edge at +0.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricFF logoFFFutureFuel Corp.REX logoREXREX American Reso…GPRE logoGPREGreen Plains Inc.BIOX logoBIOXBioceres Crop Sol…
RevenueTrailing 12 months$96M$651M$1.9B$318M
EBITDAEarnings before interest/tax-$43M$67M$122M$21M
Net IncomeAfter-tax profit-$49M$50M-$15M-$53M
Free Cash FlowCash after capex-$46M$18M$90M$37M
Gross MarginGross profit ÷ Revenue+0.1%+12.7%+1.8%+39.1%
Operating MarginEBIT ÷ Revenue-55.3%+8.6%+1.2%+0.2%
Net MarginNet income ÷ Revenue-51.6%+7.7%-0.8%-16.6%
FCF MarginFCF ÷ Revenue-48.0%+2.7%+4.7%+11.5%
Rev. Growth (YoY)Latest quarter vs prior year-67.7%+0.4%-25.9%-16.4%
EPS Growth (YoY)Latest quarter vs prior year-5.2%+2.9%+134.2%-37.3%
REX leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

BIOX leads this category, winning 3 of 6 comparable metrics.

On an enterprise value basis, REX's 16.6x EV/EBITDA is more attractive than GPRE's 103.8x.

MetricFF logoFFFutureFuel Corp.REX logoREXREX American Reso…GPRE logoGPREGreen Plains Inc.BIOX logoBIOXBioceres Crop Sol…
Market CapShares × price$211M$1.6B$1.1B$30M
Enterprise ValueMkt cap + debt − cash$159M$1.4B$1.5B$274M
Trailing P/EPrice ÷ TTM EPS-4.25x29.50x-9.14x-0.58x
Forward P/EPrice ÷ next-FY EPS est.62.81x46.62x
PEG RatioP/E ÷ EPS growth rate0.55x
EV / EBITDAEnterprise value multiple16.60x103.82x20.01x
Price / SalesMarket cap ÷ Revenue2.20x2.50x0.55x0.09x
Price / BookPrice ÷ Book value/share1.36x2.67x1.44x0.10x
Price / FCFMarket cap ÷ FCF17.84x0.85x
BIOX leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

REX leads this category, winning 7 of 9 comparable metrics.

REX delivers a 7.7% return on equity — every $100 of shareholder capital generates $8 in annual profit, vs $-29 for FF. REX carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to BIOX's 0.94x. On the Piotroski fundamental quality scale (0–9), REX scores 5/9 vs BIOX's 3/9, reflecting solid financial health.

MetricFF logoFFFutureFuel Corp.REX logoREXREX American Reso…GPRE logoGPREGreen Plains Inc.BIOX logoBIOXBioceres Crop Sol…
ROE (TTM)Return on equity-28.6%+7.7%-2.0%-16.7%
ROA (TTM)Return on assets-23.5%+6.7%-1.0%-6.7%
ROICReturn on invested capital-39.8%+11.4%-5.2%-0.5%
ROCEReturn on capital employed-51.6%+10.1%-6.2%-0.8%
Piotroski ScoreFundamental quality 0–93543
Debt / EquityFinancial leverage0.03x0.66x0.94x
Net DebtTotal debt minus cash-$51M-$175M$326M$244M
Cash & Equiv.Liquid assets$51M$196M$182M$33M
Total DebtShort + long-term debt$0$21M$508M$277M
Interest CoverageEBIT ÷ Interest expense-130.01x-0.08x-0.07x
REX leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

REX leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in REX five years ago would be worth $34,996 today (with dividends reinvested), compared to $317 for BIOX. Over the past 12 months, GPRE leads with a +336.6% total return vs BIOX's -88.5%. The 3-year compound annual growth rate (CAGR) favors REX at 50.8% vs BIOX's -64.0% — a key indicator of consistent wealth creation.

MetricFF logoFFFutureFuel Corp.REX logoREXREX American Reso…GPRE logoGPREGreen Plains Inc.BIOX logoBIOXBioceres Crop Sol…
YTD ReturnYear-to-date+52.8%+50.2%+60.1%-65.0%
1-Year ReturnPast 12 months+26.3%+147.6%+336.6%-88.5%
3-Year ReturnCumulative with dividends+3.6%+243.1%-46.8%-95.3%
5-Year ReturnCumulative with dividends-16.9%+250.0%-48.5%-96.8%
10-Year ReturnCumulative with dividends+55.5%+464.7%+21.3%-95.1%
CAGR (3Y)Annualised 3-year return+1.2%+50.8%-19.0%-64.0%
REX leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — FF and REX each lead in 1 of 2 comparable metrics.

REX is the less volatile stock with a 0.36 beta — it tends to amplify market swings less than BIOX's 1.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. FF currently trades 93.8% from its 52-week high vs BIOX's 9.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricFF logoFFFutureFuel Corp.REX logoREXREX American Reso…GPRE logoGPREGreen Plains Inc.BIOX logoBIOXBioceres Crop Sol…
Beta (5Y)Sensitivity to S&P 5000.49x0.36x1.22x1.94x
52-Week HighHighest price in past year$5.12$53.36$18.94$5.18
52-Week LowLowest price in past year$3.09$19.44$3.39$0.35
% of 52W HighCurrent price vs 52-week peak+93.8%+91.2%+86.9%+9.1%
RSI (14)Momentum oscillator 0–10063.359.154.344.6
Avg Volume (50D)Average daily shares traded520K204K1.5M804K
Evenly matched — FF and REX each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: FF as "Buy", REX as "Buy", GPRE as "Buy". Consensus price targets imply 23.3% upside for REX (target: $60) vs -16.2% for GPRE (target: $14).

MetricFF logoFFFutureFuel Corp.REX logoREXREX American Reso…GPRE logoGPREGreen Plains Inc.BIOX logoBIOXBioceres Crop Sol…
Analyst RatingConsensus buy/hold/sellBuyBuyBuy
Price TargetConsensus 12-month target$60.00$13.80
# AnalystsCovering analysts4320
Dividend YieldAnnual dividend ÷ price+0.0%
Dividend StreakConsecutive years of raises00
Dividend / ShareAnnual DPS$0.00
Buyback YieldShare repurchases ÷ mkt cap0.0%+0.9%+2.6%+3.1%
Insufficient data to determine a leader in this category.
Key Takeaway

REX leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BIOX leads in 1 (Valuation Metrics). 1 tied.

Best OverallREX American Resources Corp… (REX)Leads 3 of 6 categories
Loading custom metrics...

FF vs REX vs GPRE vs BIOX: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is FF or REX or GPRE or BIOX a better buy right now?

For growth investors, Green Plains Inc.

(GPRE) is the stronger pick with -14. 9% revenue growth year-over-year, versus -60. 7% for FutureFuel Corp. (FF). REX American Resources Corporation (REX) offers the better valuation at 29. 5x trailing P/E (62. 8x forward), making it the more compelling value choice. Analysts rate FutureFuel Corp. (FF) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — FF or REX or GPRE or BIOX?

On forward P/E, Green Plains Inc.

is actually cheaper at 46. 6x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — FF or REX or GPRE or BIOX?

Over the past 5 years, REX American Resources Corporation (REX) delivered a total return of +250.

0%, compared to -96. 8% for Bioceres Crop Solutions Corp. (BIOX). Over 10 years, the gap is even starker: REX returned +464. 7% versus BIOX's -95. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — FF or REX or GPRE or BIOX?

By beta (market sensitivity over 5 years), REX American Resources Corporation (REX) is the lower-risk stock at 0.

36β versus Bioceres Crop Solutions Corp. 's 1. 94β — meaning BIOX is approximately 432% more volatile than REX relative to the S&P 500. On balance sheet safety, REX American Resources Corporation (REX) carries a lower debt/equity ratio of 3% versus 94% for Bioceres Crop Solutions Corp. — giving it more financial flexibility in a downturn.

05

Which is growing faster — FF or REX or GPRE or BIOX?

By revenue growth (latest reported year), Green Plains Inc.

(GPRE) is pulling ahead at -14. 9% versus -60. 7% for FutureFuel Corp. (FF). On earnings-per-share growth, the picture is similar: REX American Resources Corporation grew EPS -4. 9% year-over-year, compared to -1704. 7% for Bioceres Crop Solutions Corp.. Over a 3-year CAGR, BIOX leads at 0. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — FF or REX or GPRE or BIOX?

REX American Resources Corporation (REX) is the more profitable company, earning 9.

1% net margin versus -51. 6% for FutureFuel Corp. — meaning it keeps 9. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: REX leads at 10. 0% versus -55. 3% for FF. At the gross margin level — before operating expenses — BIOX leads at 39. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is FF or REX or GPRE or BIOX more undervalued right now?

On forward earnings alone, Green Plains Inc.

(GPRE) trades at 46. 6x forward P/E versus 62. 8x for REX American Resources Corporation — 16. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for REX: 23. 3% to $60. 00.

08

Which pays a better dividend — FF or REX or GPRE or BIOX?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is FF or REX or GPRE or BIOX better for a retirement portfolio?

For long-horizon retirement investors, REX American Resources Corporation (REX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

36), +464. 7% 10Y return). Bioceres Crop Solutions Corp. (BIOX) carries a higher beta of 1. 94 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (REX: +464. 7%, BIOX: -95. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between FF and REX and GPRE and BIOX?

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

FF

Quality Business

  • Sector: Basic Materials
  • Market Cap > $100B
Run This Screen
Stocks Like

REX

Quality Business

  • Sector: Basic Materials
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Stocks Like

GPRE

Quality Business

  • Sector: Basic Materials
  • Market Cap > $100B
Run This Screen
Stocks Like

BIOX

Quality Business

  • Sector: Basic Materials
  • Market Cap > $100B
  • Gross Margin > 23%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform FF and REX and GPRE and BIOX on the metrics below

Revenue Growth>
%
(FF: -67.7% · REX: 0.4%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.